Anti-neutrophil cytoplasmic antibodies and pathogenesis of small vessel vasculitides

Autoimmunity Reviews

Volumn 2, Issue 3, 2003, Pages 158-164

  Csernok, Elena ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Anti neutrophil cytoplasmic antibodies; Pathogenesis; Vasculitis

Indexed keywords

NEUTROPHIL CYTOPLASMIC ANTIBODY; MYELOBLASTIN; PEROXIDASE; SERINE PROTEINASE;

BLOOD VESSEL INJURY; CHURG STRAUSS SYNDROME; DISEASE ASSOCIATION; GLOMERULONEPHRITIS; HUMAN; NONHUMAN; PATHOGENESIS; PHENOTYPE; REVIEW; SMALL VESSEL VASCULITIS; WEGENER GRANULOMATOSIS; ANIMAL; IMMUNOLOGY; PATHOLOGY; VASCULITIS;

ANIMALS; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; CHURG-STRAUSS SYNDROME; HUMANS; MYELOBLASTIN; PEROXIDASE; SERINE ENDOPEPTIDASES; VASCULITIS; WEGENER GRANULOMATOSIS;

EID: 0141707759     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1568-9972(03)00010-7     Document Type: Review

References (25)

1. Hoffman G.S., Specks U. Antineutrophil cytoplasmic antibodies. Arthritis Rheum. 41:1998;1521-1537.
2. Hagen E.C., Daha M.R., Hermans J., et al. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR project for ANCA assay standardization. Kidney Int. 53:1998;743-753.
3. Kallenberg C.G., Tervaert J.W. What is new with anti-neutrophil cytoplasmic antibodies: diagnostic, pathogenetic and therapeutic implications. Curr Opin Nephrol Hypertens. 8:1999;307-315.
4. Choi H.K., Lamprecht P., Niles J.L., Gross W.L., Merkel P.A. Subacute bacterial endocarditis with positive cytoplasmic antineutrophil cytoplasmic antibodies and anti-proteinase 3 antibodies. Arthritis Rheum. 43:(1):2000;226-231.
5. Voswinkel J, Müller A, Lamprecht P, Gross WL, Gause A. Does ANCA formation result from an antigen-triggered immune response in Wegener's endonasal inflamed tissue. Clev Clinic J Med 2002;69(SII-159)38-129. 10th International Vasculitis and ANCA Workshop, Cleveland, April 25-28, 2002.
6. van der Geld Y.M., Limburg P.C., Kallenberg C.G. Proteinase 3, Wegener's autoantigen: from gene to antigen. J Leukoc Biol. 69:2001;177-190.
7. Yang J.J., Preston G.A., Pendergraft W.F., et al. Internalization of proteinase 3 is concomitant with endothelial cell apoptosis and internalization of myeloperoxidase with generation of intracellular oxidants. Am J Pathol. 158:(2):2001;581-592.
8. Preston G.A., Yang J.J., Xiao H., Falk R.J. Understanding the pathogenesis of ANCA: where are we today? Clev Clin J Med. 69:(Suppl. 2):2002;SII51-SII54.
9. Harper L., Cockwell P., Dwoma A., Savage C. Neutrophil priming and apoptosis in ANCA-associated vasculitis. Kidney Int. 59:2001;1729-1738.
10. Witko-Sarsat V., Lesavre P., Lopez S., et al. A large subset of neutrophils expressing membrane proteinase 3 is a risk factor for vasculitis and rheumatoid arthritis. J Am Soc Nephrol. 10:1999;1224-1233. in process citation.
11. Csernok E., Ernst M., Schmitt W., Bainton D.F., Gross W.L. Activated neutrophils express proteinase 3 on their plasma membrane in vitro and in vivo. Clin Exp Immunol. 95:1994;244-250.
12. Muller-Kobold A.C., Mesander G., Stegemann C.A., Kallenberg C.G.M., Cohen Tervaert J.W. Are circulating neutrophils intravascularly activated in patients with anti-neutrophil cytoplasmatic antibody associated vasculitides? Clin Exp Immunol. 114:(3):1998;491-499.
13. Franssen C.F., Gans R.O., Arends B., et al. Differences between anti-myeloperoxidase and anti-proteinase 3 associated renal disease. Kidney Int. 47:1995;193-199.
14. Franssen C., Gans R., Kallenberg C., Hageluken C., Hoorntje S. Disease spectrum of patients with antineutrophil cytoplasmic autoantibodies of defined specificity: distinct differences between patients with anti-proteinase 3 and anti-myeloperoxidase autoantibodies. J Int Med. 244:1998;209-216.
15. Schönermarck U., Lamprecht P., Csernok E., Gross W.L. Prevalence and spectrum of rheumatic diseases associated with proteinase 3-antineutrophil cytoplasmic antibodies (ANCA) and myeloperoxidase-ANCA. Rheumatology (Oxford). 40:2001;178-184.
16. Hauer H.A., Bajema I.M., van Houwelingen H.C., et al. Renal histology in ANCA-associated vasculitis: differences between diagnostic and serologic subgroups. Kidney Int. 61:2002;80-89.
17. Specks U. ANCA subsets: influence on disease phenotype. Clev Clin J Med. 69:(Suppl. 2):2002;SII56-SII59.
18. Csernok E., Müller A., Gross W.L. Immunopathology of ANCA-associated vasculitis. Int Med. 38:(10):1999;759-765.
19. Gilligan H.M., Bredy B., Brady H.R., et al. Antineutrophil cytoplasmic autoantibodies interact with primary granule constituents on the surface of apoptotic neutrophils in the absence of neutrophil priming. J Exp Med. 184:1996;2231-2241.
20. Moosig F., Csernok E., Kumanovics G., Gross W.L. Opsonization of apoptotic neutrophils by anti-neutrophil cytoplasmic antibodies (ANCA) leads to enhanced uptake by macrophages and increased release of TNF-alpha. Clin Exp Immunol. 122:(3):2000;499-503.
21. Harper J.M., Thiru S., Lockwood C.M., Cooke A. Myeloperoxidase autoantibodies distinguish vasculitis mediated by anti-neutrophil cytoplasmatic antibdies from immune complex disease in MRL/Mp-Ipr/Ipr mice: a spontaneous model for microscopic angiitis. Eur J Immunol. 28:1998;2217-2226.
22. Patry Y.C., Trewick D.C., Gregoire M., et al. Rats injected with syngenic rat apoptotic neutrophils develop anti-neutrophil cytoplasmic antibodies. J Am Soc Nephrol. 12:(8):2001;1764-1768.
23. Specks U. Are animal models of vasculitis suitable tools? Curr Opin Rheumatol. 12:2000;11-19.
24. Heeringa P., Brouwer E., Cohen Tervaert J.W., Weening J.J., Kallenberg C.G. Animal models of anti-neutrophil cytoplasmic antibody associated vasculitis. Kidney Int. 53:(2):1998;253-263.
25. Xiao H., Heeringa P., Hu P., et al. Antineutrophil cytoplasmatic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest. 110:2002;955-963.